A New Tool for Helping Labs Improve Diversity in Clinical Trials
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
In last week’s key cases, those involved in UDT fraud schemes face the music, and a doctor is convicted of stealing COVID relief money.
The recent Declaration of North America makes updating the current North American Plan for Animal and Pandemic Influenza a priority.
Dispute resolution mechanism is being overwhelmed by unexpected case volume and complexity.
While most recent cases were the usual FCA and kickback-related issues, one involved the mischarging of federal grants by two biotech companies and their co-founder.
DNA sequencing technologies may revolutionize the early detection and prevention of the disease.
Though the federal spending bill passed at the end of December offers another year’s reprieve from PAMA price cuts, SALSA was not included.
Merger and acquisition deal volume and value were down last year, but deal impact was not.
What labs need to know to maximize travel allowance reimbursements.
Labs will be able to bill their MACs for the newly recognized tests starting April 1, 2023.
Last week’s cases saw a major false claims-related settlement, as well as many kickback-related schemes.